Literature DB >> 9392578

Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology.

W Brück1, A Bitsch, H Kolenda, Y Brück, M Stiefel, H Lassmann.   

Abstract

Magnetic resonance imaging (MRI) is widely used to evaluate and monitor disease activity in inflammatory demyelinating central nervous system (CNS) diseases such as multiple sclerosis. The present study aimed at correlating MRI findings with histological parameters in 6 cases of biopsy-proven inflammatory demyelination of the CNS. The earliest stages of demyelinating activity manifested as almost isointense lesions with a massive gadolinium-DTPA (Gd-DTPA) enhancement in T1-weighted scans. In T2-weighted scans, early active lesions formed a border of decreased intensity compared with the lesion center and the perifocal edema. The morphological correlate of this pattern in our patients was activated macrophages in the zone of myelin destruction at the plaque border. Late active lesions were hypointense in T1 and hyperintense in T2 scans. Inactive demyelinated and remyelinating lesions were hyperintense in T2 scans and enhanced inhomogenously after Gd-DTPA application. T1 scans revealed major differences in the degree of hypointensity that correlated with the extent of axonal damage, extracellular edema, and the degree of demyelination or remyelination.

Entities:  

Mesh:

Year:  1997        PMID: 9392578     DOI: 10.1002/ana.410420515

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  97 in total

1.  Dirty-appearing white matter in multiple sclerosis: volumetric MR imaging and magnetization transfer ratio histogram analysis.

Authors:  Yulin Ge; Robert I Grossman; James S Babb; Juan He; Lois J Mannon
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

Review 2.  What do we know about the mechanism of action of disease-modifying treatments in MS?

Authors:  Hans-Peter Hartung; Amit Bar-Or; Yannis Zoukos
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

3.  Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla.

Authors:  M Inglese; G Madelin; N Oesingmann; J S Babb; W Wu; B Stoeckel; J Herbert; G Johnson
Journal:  Brain       Date:  2010-01-27       Impact factor: 13.501

4.  Absence of perforin expression confers axonal protection despite demyelination.

Authors:  Charles L Howe; Jaimie D Adelson; Moses Rodriguez
Journal:  Neurobiol Dis       Date:  2006-11-16       Impact factor: 5.996

Review 5.  Imaging of multiple sclerosis: role in neurotherapeutics.

Authors:  Rohit Bakshi; Alireza Minagar; Zeenat Jaisani; Jerry S Wolinsky
Journal:  NeuroRx       Date:  2005-04

Review 6.  Magnetic resonance spectroscopy in the monitoring of multiple sclerosis.

Authors:  Ponnada A Narayana
Journal:  J Neuroimaging       Date:  2005       Impact factor: 2.486

7.  Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration.

Authors:  S Schilling; S Goelz; R Linker; F Luehder; R Gold
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

Review 8.  Magnetic resonance imaging of myelin.

Authors:  Cornelia Laule; Irene M Vavasour; Shannon H Kolind; David K B Li; Tony L Traboulsee; G R Wayne Moore; Alex L MacKay
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

9.  The effect of interferon beta-1b on size of short-lived enhancing lesions in patients with multiple sclerosis.

Authors:  Deeya Gaindh; Neal Jeffries; Joan Ohayon; Nancy D Richert; Clelia Pellicano; Joseph A Frank; Henry McFarland; Francesca Bagnato
Journal:  Expert Opin Biol Ther       Date:  2008-12       Impact factor: 4.388

10.  Initial investigation of the blood-brain barrier in MS lesions at 7 tesla.

Authors:  María I Gaitán; Pascal Sati; Souheil J Inati; Daniel S Reich
Journal:  Mult Scler       Date:  2012-12-17       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.